ChiCTR1800020309: Autophagy mechanism of ovarian EMs cells with intervention of Luo's prescription for endometriosis based on PI3K/Akt/mTOR signaling pathway: an in vitro study |
|
|
| Not yet recruiting | N/A | 200 | | None ;Luo 's prescription for endometriosis ;Luo 's prescription for endometriosis ;Luo 's prescription for endometriosis ;Danazol ;Danazol ;Danazol ;Temsirolimus ;Temsirolimus ;Temsirolimus | The First Affiliated Hospital of Guangzhou University of Chinese Medicine; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Traditional Chinese Medicine Bureau Of Guangdong Province | Endometriosis | | | | |
NCT03724097: Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy |
|
|
| Active, not recruiting | N/A | 200 | US, RoW | RNA sequencing, RNA-seq, Transcriptome analysis, target drug with the score above 0,1, target drug with the score equal or below 0,1, non-target drug, palliative care | OmicsWay Corp., Oncobox Ltd, Vitamed LLC, N.N. Blokhin National Medical Research Center of Oncology, Kaluga Regional Clinical Oncology Center, Multidisciplinary medical holding SM-Clinic, Oncological Clinical Dispensary No. 1 of the Moscow City Health Department | Cancer | 04/21 | 11/22 | | |
COMBOREIN, NCT03571438: Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors |
|
|
| Recruiting | N/A | 100 | Europe | CK2 and ATM inhibitors serine/ threonin Kinase combination, Sunitinib, Pazopanib, Temsirolimus | University Hospital, Grenoble | Kidney Cancer | 09/22 | 09/24 | | |
PDXovo, NCT04602702: Hyper-Personalized Medicine Using Patient Derived Xenografts () for Metastatic Solid Tumors |
|
|
| Recruiting | N/A | 50 | Canada | | Sunnybrook Health Sciences Centre | Kidney Neoplasm, Carcinoma, Renal Cell, Metastatic Solid Tumor | 12/22 | 12/22 | | |
